Contact Us

Empowering Oncology Care: Clinical Evidence for Improving Patient Outcomes

  • Clinical Conditions

Food alone is often insufficient to cover all your cancer patients’ nutritional needs 1-2

A person wearing a yellow ribbed sweater is seen adjusting their hair in a bright, modern living room. The setting features a cozy sofa and lush green indoor plants near large windows, creating a relaxed and natural ambiance. The sunlight streaming through the windows adds warmth to the scene.

ESPEN recognises the importance of supplementing food with medical nutrition as an integral part of cancer care.**2  Dietary challenges such as appetite decline and reduced protein intake, and lifestyle choices, such as a plant-based diet, and sensory issues may impact nutritional intake and overall health. 3-10

6-300x212.png

Appetite decline

Almost two thirds of cancer patients have experienced eating problems as a consequence of their treatment. They report they eat less due to a loss of appetite, feeling full quickly, and not feeling like eating. A significant 57% of patients report having lost more than 10% of their body weight during cancer.³

7/2024/11/7-300x212.png

Sensory issues

Up to 70% of patients with cancer experience taste and smell changes, that may develop throughout the course of the disease and up to 1 year after treatment.⁷ Alterations in the senses can lead to a reduction in food intake resulting in increased weight loss.⁷⁻⁸

6-300x212.png

Reduced protein intake

Patients with cancer need up to twice as much protein as healthy adults⁴⁻⁵ but up to 2 in 3 patients are not meeting their recommended protein requirements.⁶

7/2024/11/7-300x212.png

Plant-based lifestyle

29% of Australians use plant-based, milk alternatives at least once per week and the number is increasing.⁹ In the next 12 months, 34% of Australians are likely to become vegan or vegetarian.¹⁰ For these patients, ESPEN recognises the importance of supplementing food with medical nutrition as an integral part of cancer care.²

Help maximise cancer treatment with the right medical nutrition

Help maximise cancer treatment with the right medical nutrition

 

[/col_inner] [/column_grid_inner]

Bar graph comparing protein intake between Compact Protein and Standard of Care over a 12-week period. Key milestones include baseline, end of 1st week, end of 2nd week, and week 12. Numeric values such as 45%, 88%, 55%, 40%, and 77% are prominently displayed. The chart highlights ESPEN protein recommendations (>1g/kg/d).

Cancer-related malnutrition

 

Fortisip Compact Protein our low volume, high protein formula enabled patients with cancer to meet ESPEN recommended protein intake. 6

For the dietary management of patients with or at risk of disease related malnutrition

 

Cancer-related malnutrition and taste alterations

 

Fortisip Compact Protein Sensations, our compact high protein formula with sensory-adapted flavours has been validated as ‘liked by patients’ undergoing cancer treatment11 and provides a cool or warm taste sensation.

A circular infographic highlights that 84% of participants preferred Cool Red Fruits. The design features a gradient purple color scheme with bold text in the center. The visual emphasizes data-driven insights with a clean and modern style.

92-94% liked

Cool Red Fruit

A circular infographic highlights survey results with 68% of participants favoring Hot Tropical Ginger. The design features an orange gradient ring and bold text in orange and purple. The visual is clean and modern, emphasizing the numeric data prominently.

65-69% liked

Hot Tropical Ginger

For the dietary management of disease related malnutrition.

 

Cancer-related malnutrition and dairy alternative

 

Fortisip Compact Protein Sensations, our compact high protein formula with sensory-adapted flavours has been validated as ‘liked by patients’ undergoing cancer treatment11 and provides a cool or warm taste sensation.

A bar chart displaying two vertical bars with percentages. The first bar, in gray, represents 63%, while the second bar, in green, represents 88%. The chart is labeled with 'Baseline' and 'Fortis Protocol' beneath the respective bars.

Fortisip PlantBased our unique vegan formula is a high-quality blend of pea and soy protein that achieved greater compliance than baseline~ Prescribed ONS 12 and is suitable as a sole Plant-based source of nutrition.#

[/col] [/column_grid]

For the dietary management of patients with or at risk of disease related malnutrition due to cancer, chronic catabolic disease or cachexia.

 

Download our Empowering Oncology Care booklet for summaries of the latest clinical evidence to improve patient outcomes.

Fortisip products are food for special medical purposes and must be used under medical supervision.

 

^Compared to healthy adults, whose protein requirements is 0.84 g/kg/day, adults with cancer are recommended to have >1.2g/kg/day and up to 2g/kg/day.

 

** According to ESPEN guidelines, the additional use of ONS is advised when an enriched diet is not effective in reaching nutritional goals. Medical nutrition is indicated if patients are unable to eat adequately (e.g. less than 50% of the requirement for more than one week or only 50–75% of the requirement for more than two weeks).

 

~ Prior to commencing the study patients (n=8) were taking a different oral nutritional supplement.

 

#In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5.

Caccialanza R, et al. Supp Care in Cancer Jul 2022.
Muscaritoli M, et al. Oncotarget Advance Publications. Aug 2017;1-13.
Data on file: IPSOS, Nutrition in Cancer Care survey. 2023.
Arends J, et al. ESMO Open. 2021;6(3):100092.
Arends J, et al. Clin Nutr. 2017;36(1):11-48.
Dingemans AM, et al. Nutrients. 2023;15(24):5030.
Spotten LE, et al. Ann Oncol. 2017;28(5):969-984
Brisbois TD, et al. J Pain Symptom Manae. 2011;41:673-83.
Plant Based Eating. CHOICE 2021.
Understanding the New Asian Consumer. PwC, Rabobank and Temasek 2020. Available at: The Asia Food Challenge 2021 (pwc.co.nz) (Accessed September 2023).
de Haan JJ, et al. Support Care Cancer. 2021;29:5691-9.
Nutricia UK ACBS trial, data on file 2022.

 Nutricia products are intended for the nutritional management of diseases and related medical conditions and therefore should be used under medical supervision.

x